Company news
Neurocrine Biosciences, Inc. news in 2020
Neurocrine Biosciences, Inc.'s news releases, calls and decks from 2020, newest first.
Neurocrine Biosciences Reports Third Quarter 2020 Financial Results
November 8, 2020
Neurocrine Biosciences Announces Conference Call and Webcast of Third Quarter 2020 Financial Results
October 5, 2020
Neurocrine Biosciences Announces Once-Daily ONGENTYS® (opicapone) Now Available in the U.S. as an Add-On Treatment for Patients with Parkinson's Disease Experiencing "Off" Episodes
September 13, 2020
Neurocrine Biosciences Reports Second Quarter 2020 Financial Results
August 2, 2020
Neurocrine Biosciences Announces Conference Call and Webcast of Second Quarter 2020 Financial Results
July 12, 2020
Neurocrine Biosciences and Takeda Announce Collaboration to Develop and Commercialize Potential Therapies for Psychiatric Disorders
June 15, 2020
Neurocrine Biosciences Exercises Option to License Idorsia's Novel Treatment for Rare Pediatric Epilepsy
May 10, 2020
Neurocrine Biosciences Reports First Quarter 2020 Financial Results
May 5, 2020
Neurocrine Biosciences Announces FDA Approval of Once-Daily ONGENTYS® (opicapone) as an Add-On Treatment for Patients with Parkinson's Disease Experiencing "Off" Episodes
April 26, 2020
Neurocrine Biosciences Announces Conference Call and Webcast of First Quarter 2020 Financial Results
April 14, 2020
Neurocrine Biosciences Provides COVID-19 Business Update
April 2, 2020
Neurocrine Biosciences Reports Fourth Quarter and Full-Year 2019 Financial Results
February 3, 2020
Neurocrine Biosciences Announces Appointment of Shalini Sharp to Board of Directors
February 2, 2020
Neurocrine Biosciences Announces Conference Call and Webcast of Fourth Quarter and Year-End 2019 Financial Results
January 19, 2020
Neurocrine Biosciences Provides Preliminary Fourth Quarter and Full-Year 2019 Net Product Sales Results and 2020 Program Milestones
January 11, 2020
Neurocrine Biosciences and Idorsia Amend Option Agreement to License Novel Treatment for Rare Pediatric Epilepsy
January 9, 2020
Calls in 2020
Decks in 2020
- Q4 2019 Earnings Presentation
Earnings · 26 slides · Feb 4, 2020